Ever Source Wealth Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,285 shares of CLDX stock, worth $25,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,285
Previous 407
215.72%
Holding current value
$25,545
Previous $13,000
146.15%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
69.7MCall Options Held
960KPut Options Held
675K-
Wellington Management Group LLP Boston, MA8.98MShares$178 Million0.04% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.06MShares$101 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$93.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$77.2 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$74.6 Million1.82% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $930M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...